Baseline Albuminuria

Adults in Tanzania living with HIV and taking tenofovir have a higher rate of chronic kidney disease vs. those without the viral infection, according to a prospective cohort study.

Patients with type 2 diabetes and chronic kidney disease receiving empagliflozin were less likely to experience a decline in eGFR compared with patients taking placebo, results from a newly published study show.